Ningbo Menovo Pharmaceutical Co.,Ltd.’s Net Profit Rose 62.9% in First Half of 2022

Ningbo Menovo Pharmaceutical Co.,Ltd. (宁波美诺华药业股份有限公司) (603538.SH) reported a net profit of 205.6 million yuan in the first half of 2022, up 62.9% year-on-year.

Meanwhile, the company posted 897.3 million yuan in revenue, up 29.7% year-on-year.

At the end of the reporting period, it had 4.4 billion yuan in total assets and 2.3 billion yuan in total liabilities, with a liability-to-asset ratio of 53.1%.